Skip to main content
SpringerLink
Log in

Onchocerciasis

  • Chapter
Intraocular Inflammation

Abstract

Onchocerciasis, or river blindness, is a major tropical parasitic infection caused by the filarial worm, Onchocerca volvulus. The first manifestation of infection is usually intense pruritus, and subsequently a wide variety of skin and eye changes develop, with ocular damage being the most serious complication.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abiose A (1998) Onchocercal eye disease and the impact of Mectizan treatment. Ann Trop Med Parasitol 92(Suppl 1):S11–S22

    Article  CAS  PubMed  Google Scholar 

  2. Abiose A, Jones BR, Cousens SN et al (1993) Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet 341(8838):130–134

    Article  CAS  PubMed  Google Scholar 

  3. African Programme for Onchocerciasis Research (APOC) (2005) Final communique of the 11th session of the Joint Action Forum (JAF) of APOC, Paris, France. APOC, Ouagadougou (Burkina Faso), pp 6–9, Ref Type: Generic

    Google Scholar 

  4. Aziz MA, Diallo S, Diop IM et al (1982) Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 2(8291):171–173

    Article  CAS  PubMed  Google Scholar 

  5. Basanez MG, Pion SD, Churcher TS et al (2006) River blindness: a success story under threat? PLoS Med 3:e371

    Article  PubMed Central  PubMed  Google Scholar 

  6. Bird AC, Anderson J, Fuglsang H (1976) Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol 60:2–20

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Bird AC, el-Sheikh H, Anderson J et al (1979) Visual loss during oral diethylcarbamazine treatment for onchocerciasis. Lancet 2(8132):46

    Article  CAS  PubMed  Google Scholar 

  8. Bird AC, el-Sheikh H, Anderson J et al (1980) Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. Br J Ophthalmol 64:191–200

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Boatin BA, Toe L, Alley ES et al (1998) Diagnostics in onchocerciasis: future challenges. Ann Trop Med Parasitol 92(Suppl 1):S41–S45

    PubMed  Google Scholar 

  10. Brattig NW, Bazzocchi C, Kirschning et al (2004) The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. J Immunol 173:437–445

    Article  CAS  PubMed  Google Scholar 

  11. Braun G, McKechnie GW (1995) Molecular and immunological characterization of hr44, a human ocular component immunologically crossreactive antigen Ov39 of Onchocerca volvulus. J Exp Med 182:1121–1132

    Article  CAS  PubMed  Google Scholar 

  12. Braun G, McKechnie NM, Connor V et al (1991) Immunological crossreactivity between a cloned antigen of Onchocerca volvulus and a component of the retinal pigment epithelium. J Exp Med 174:169–177

    Article  CAS  PubMed  Google Scholar 

  13. Centers for Disease Control and Prevention (CDC) (2013) Progress toward elimination of onchocerciasis in the Americas – 1993–2012. MMWR Morb Mortal Wkly Rep 62:405

    Google Scholar 

  14. Chippaux JP, Boussinesq M, Fobi G et al (1999) Effect of repeated ivermectin treatments on ocular onchocerciasis: evaluation after six to eight doses. Ophthalmic Epidemiol 6:229–246

    Article  CAS  PubMed  Google Scholar 

  15. Choyce DP (1971) Impacted microfilaria in the lens capsule. Br J Ophthalmol 55:861

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Cousens SN, Yahaya H, Murdoch I et al (1997) Risk factors for optic nerve disease in communities mesoendemic for savannah onchocerciasis, Kaduna State, Nigeria. Trop Med Int Health 2:89–98

    Article  CAS  PubMed  Google Scholar 

  17. Duke BOL (1966) Onchocerca-Simulium complexes: III – the survival of Simulium damnosum after high intakes of microfilariae of incompatible strains of Onchocerca volvulus and the survival of the parasites in the fly. Ann Trop Med Parasitol 6:495–500

    Google Scholar 

  18. Enk CD, Anteby I, Abramson N et al (2003) Onchocerciasis among Ethiopian immigrants in Israel. Isr Med Assoc J 5:485–488

    PubMed  Google Scholar 

  19. Evans TG (1995) Socioeconomic consequences of blinding onchocerciasis in west Africa. Bull World Health Organ 73:495–506

    PubMed Central  CAS  PubMed  Google Scholar 

  20. Hise AG, Daehnel K, Gillette-Ferguson I et al (2007) Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J Immunol 178:1068–1076

    Article  CAS  PubMed  Google Scholar 

  21. Hissette J (1938) Ocular onchocerciasis. Am J Trop Med Hyg 18(Suppl):58–90

    Google Scholar 

  22. Hoerauf A (2008) Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis 21:673

    Article  CAS  PubMed  Google Scholar 

  23. Hoerauf A, Mand S, Adjei O et al (2001) Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet 357:1415

    Article  CAS  PubMed  Google Scholar 

  24. Hoerauf A, Specht S, Büttner M et al (2008) Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med Microbiol Immunol 197:295

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Hoerauf A, Volkmann L, Hamelmann C et al (2000) Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355(9211):​1242–1243

    Article  CAS  PubMed  Google Scholar 

  26. http://www.cdc.gov/dpdx/onchocerciasis/tx.html

  27. Kaifi JT, Diaconu E, Pearlman E (2001) Distinct roles for PECAM-1, ICAM-1, and VCAM-1 in recruitment of neutrophils and eosinophils to the cornea in ocular onchocerciasis (river blindness). J Immunol 166:​6795–6801

    Article  CAS  PubMed  Google Scholar 

  28. Kennedy MH, Bertocchi I, Hopkins AD et al (2002) The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic. Ann Trop Med Parasitol 96:​297–307

    Article  CAS  PubMed  Google Scholar 

  29. Kirkwood B, Smith P, Marshall T et al (1983) Relationships between mortality, visual acuity and microfilarial load in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg 77:862–868

    Article  CAS  PubMed  Google Scholar 

  30. McKechnie NM, Braun G, Connor V et al (1993) Immunologic cross-reactivity in the pathogenesis of ocular onchocerciasis. Invest Ophthalmol Vis Sci 34:2888–2902

    CAS  PubMed  Google Scholar 

  31. McKechnie NM, Gurr W, Yamada H et al (2002) Antigenic mimicry: onchocerca volvulus antigen-specific T cells and ocular inflammation. Invest Ophthalmol Vis Sci 43:411–418

    PubMed  Google Scholar 

  32. Murdoch ME (1992) The skin and the immune response in onchocerciasis. Trop Dr 22(Suppl 1):44–55

    Google Scholar 

  33. Murdoch I, Abiose A, Babalola O et al (1994) Ivermectin and onchocercal optic neuritis: short-term effects. Eye 8:456–461

    Article  PubMed  Google Scholar 

  34. Murdoch ME, Asuzu MC, Hagan M et al (2002) Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann Trop Med Parasitol 96:283–296

    Article  CAS  PubMed  Google Scholar 

  35. Murdoch ME, Hay RJ, Mackenzie CD et al (1993) A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br J Dermatol 129:260–269

    Article  CAS  PubMed  Google Scholar 

  36. Murray CJ, Vos T, Lozano R et al (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197–2223

    Article  PubMed  Google Scholar 

  37. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control (1995) World Health Organ Tech Rep Ser 852:1–104

    Google Scholar 

  38. Park J, Dickerson TJ, Janda KD (2008) Major sperm protein as a diagnostic antigen for onchocerciasis. Bioorg Med Chem 16:7206–7209

    Article  CAS  PubMed  Google Scholar 

  39. Remme JHF (2004) The global burden of onchocerciasis in 1990. World Health Organization, Geneva, http://www.who.int/healthinfo/statistics/bod_onchocercaisis1990.pdf

    Google Scholar 

  40. Ridley H (1945) Ocular onchocerciasis. Including an investigation in the Gold Coast. Br J Ophthalmol Monograph Supplement 295:1–58

    Google Scholar 

  41. Saint AA, Blackwell NM, Hall LR et al (2002) The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 295(5561):​1892–1895

    Article  Google Scholar 

  42. Semba RD, Murphy RP, Newland HS et al (1990) Longitudinal study of lesions of the posterior segment in onchocerciasis. Ophthalmology 97:1334–1341

    Article  CAS  PubMed  Google Scholar 

  43. Taylor HR (1989) Ivermectin treatment of onchocerciasis. Aust N Z J Ophthalmol 17:435–438

    Article  CAS  PubMed  Google Scholar 

  44. Tekle AH, Elhassan E, Isiyaku S et al (2012) Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control. Parasit Vectors 5:28. doi:10.1186/1756-3305-5-28

    Article  PubMed Central  PubMed  Google Scholar 

  45. Thylefors B (1976) Intra-ocular pressure in onchocerciasis. Some preliminary results of a field evaluation. Bull World Health Organ 54:113–114

    PubMed Central  CAS  PubMed  Google Scholar 

  46. Tonjum AM, Thylefors B (1978) Aspects of corneal changes in onchocerciasis. Br J Ophthalmol 62:​458–461

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Turner JD, Tendongfor N, Esum M et al (2010) Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. PLoS Negl Trop Dis 4:e660

    Article  PubMed Central  PubMed  Google Scholar 

  48. Yang YF, Cousens S, Murdoch IE et al (2001) Intraocular pressure and gonioscopic findings in rural communities mesoendemic and nonendemic for onchoceriasis, Kaduna State, Nigeria. Eye 15:​756–759

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Watford General Hospital, Vicarage Road, Watford, Herts, WD18 0HB, UK

    M. E. Murdoch

  2. Epidemiology and International Eye Health, Department of Genetics, Institute of Ophthalmology, Bath Street, London, EC1V 9EL, UK

    Ian E. Murdoch

  3. Glaucoma department, Moorfields Eye Hospital NHS Foundation Trust, City Road, London, EC1V 2PD, UK

    Ian E. Murdoch

Authors
  1. M. E. Murdoch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ian E. Murdoch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian E. Murdoch .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Murdoch, M.E., Murdoch, I.E. (2016). Onchocerciasis. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_134

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_134

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation